Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
17 Ottobre 2024 - 2:00PM
Business Wire
New offering leverages Medidata Rave EDC,
making the world’s leading electronic clinical data capture
available to market segments historically lacking access to the
cutting-edge technology
Medidata, a Dassault Systèmes brand and leading provider of
clinical trial solutions to the life sciences industry, today
announced Medidata Rave Lite, an extension of the company’s
gold-standard clinical research software, Medidata Rave EDC,
designed explicitly for Phase I and Phase IV studies. Regardless of
company size, therapeutic focus, or pipeline, Rave Lite provides
efficient electronic clinical data capture (EDC), management, and
analysis solutions with a tailored pricing model.
While EDC is a fundamental building block of clinical trials,
technology fragmentation across phases leads to integration
challenges and delays in startup times. In particular, the lack of
access to innovative technology disproportionately affects early-
and late-stage studies. Having addressed these challenges in over
34,000 trials, Medidata is now offering superior options for Phase
I and Phase IV studies with Rave Lite.
With Medidata Designer integration, study builders can design
Phase I and Phase IV trials with speed and precision, and with the
continued use of AI, potential study misconfigurations are reduced
while securing data integrity. Thus, Rave Lite offers a consistent
experience without sacrificing the advanced power of Rave EDC.
“Rave Lite addresses a critical need in the market for early and
late-stage trials, offering a streamlined solution built on our
trusted Rave EDC platform,” said Tom Doyle, chief technology
officer, Medidata. “By giving our customers the ability to use one
EDC ubiquitously across all phases, customers gain the flexibility
to scale their studies while maintaining the high standards that
have long defined Medidata’s solutions.”
Rave EDC was recently recognized as the leading provider by
Everest Group‘s first-ever PEAK Matrix® for its effectiveness in
simplifying clinical trials for sponsors and CROs while ensuring
data quality and integrity.
Medidata will showcase Rave Lite at NEXT New York, the premier
clinical trials conference hosted by the company, in New York City
on November 13 and 14. The solution will be made available to
customers in early 2025. For more information on how Rave Lite can
benefit research, click here.
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 34,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,200 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all –consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241017355667/en/
Medidata PR Medidata.PR@3ds.com
Analyst Relations medidata.AR@3ds.com
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Mar 2024 a Mar 2025
